Clinical Trial Update: Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of neoadjuvant immunotherapy for gastric and rectal cancers using multi-omics sequencing has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Rectal Cancer

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Immunotherapy, Gastric Cancer | Phase 2 | Status: COMPLETED